| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/19/2001 | US6248556 Nucleotide sequence of guanosine triphosphate-binding protein from staphylococcus; diagnosis of infections; drug screening; bactericides; bacteriostats; vaccines; probes; primers; vectors; host cells |
| 06/19/2001 | US6248555 Nucleotide and amino acid sequence of mutant presenilin 1; diagnosis; screening; drug screening; probes; primers; host cells; vectors |
| 06/19/2001 | US6248554 DNA sequence coding for a BMP receptor |
| 06/19/2001 | US6248550 Assays for protein kinases using fluorescent protein substrates |
| 06/19/2001 | US6248548 Thrombosis prophylaxis for factor Vleiden carriers |
| 06/19/2001 | US6248545 Assay of denatured lipoproteins |
| 06/19/2001 | US6248543 Detecting microbiocides in sample; mix modulator and protein in sample and detect binding of modulator and protein |
| 06/19/2001 | US6248538 Kit for detecting antibodies against preferential bacteria; for the detection of lyme disease |
| 06/19/2001 | US6248536 Bacillus thuringiensis CryET33 and CryET34 compositions and uses thereof |
| 06/19/2001 | US6248532 Detecting modulators of regulatory element; incubate nucleotide sequences with modulators, monitor binding to nucleotide sequences, comparing binding in the presence and absence modulators |
| 06/19/2001 | US6248528 Drug screening by contacting test compound with human centrin protein and determining whether compound binds to protein |
| 06/19/2001 | US6248523 Mammalian tumor susceptibility genes and their uses |
| 06/19/2001 | US6248520 Nucleic acid molecules encoding nuclear hormone receptor coactivators and uses thereof |
| 06/19/2001 | US6248517 Amino acid sequences; diagnosis of lyme disease; recombinant production; vaccines |
| 06/19/2001 | US6248516 Library for expression of immunoglobulin heavy chain variable domains |
| 06/19/2001 | US6248513 In vitro detection of infection of cells by microorganism; incubate immunoglobulins with cells and detect the formation of protein immunoglobulin complexes |
| 06/19/2001 | US6248331 Treponema pallidum fused antigen and assay for anti-treponema pallidum antibodies using the same fused antigen |
| 06/19/2001 | US6248330 Genetic engineering; polypeptides |
| 06/19/2001 | US6248329 Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
| 06/19/2001 | US6248328 HIV-1 virus isolates of a subtype and its differential diagnostics, a vaccine against HIV-1 virus infections of this subtype and method of producing same, use of the HIV-1 virus isolates |
| 06/19/2001 | US6248326 Regulation of osteoclast formation by inhibition of osteoblastic stem cell factor |
| 06/19/2001 | US6248322 Attenuated vaccine for Blastomyces dermatitidis |
| 06/19/2001 | US6248320 Herpes simplex virus; genetic engineering |
| 06/19/2001 | US6248319 Blood disorders |
| 06/19/2001 | CA2218616C Nitrosylated neuropeptides |
| 06/19/2001 | CA2040180C Enzymatic process for the determination of beta-lactam antibiotics |
| 06/19/2001 | CA2022539C Albumin derivatives with therapeutic functions |
| 06/19/2001 | CA2011722C Reagents for the determination of drugs |
| 06/19/2001 | CA2003307C Streptolysin o antigen derivative, its production and uses |
| 06/19/2001 | CA1341257C Benzhydrylamine derivatives |
| 06/19/2001 | CA1341255C Therapeutic compositions against sterptococcal infections, transformed hosts, methods of immunization and genetically engineered products |
| 06/14/2001 | WO2001042792A2 Diagnosis of cervical cancer using marker proteins |
| 06/14/2001 | WO2001042789A1 MARKERS FOR IDENTIFICATION AND ISOLATION OF PANCREATIC ISLET α AND β CELL PROGENITORS |
| 06/14/2001 | WO2001042787A2 Immunoassay for neonicotinyl insecticides |
| 06/14/2001 | WO2001042782A1 Characterization of hybridized polymer molecules based on monomer-interface interactions |
| 06/14/2001 | WO2001042781A2 Supracolonic aerodigestive neoplasm detection |
| 06/14/2001 | WO2001042509A1 Use of multiple recombination sites with unique specificity in recombinational cloning |
| 06/14/2001 | WO2001042506A1 T1 receptor-like ligand ii and uses thereof |
| 06/14/2001 | WO2001042492A1 Engineering intracellular sialylation pathways |
| 06/14/2001 | WO2001042486A1 Axor12 |
| 06/14/2001 | WO2001042485A1 Sequence and method for increasing protein expression in cellular expression systems |
| 06/14/2001 | WO2001042484A1 Il-6 like polynucleotide |
| 06/14/2001 | WO2001042479A2 Insecticide targets and methods of use |
| 06/14/2001 | WO2001042478A1 A recombinant virus killing specifically eb-related tumor, the method for constructing and propagating it and the use thereof |
| 06/14/2001 | WO2001042472A2 DNA ENCODING A NOVEL PROST-Ets POLYPEPTIDE |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042470A1 Nucleic acid and protein expressed thereby and their involvement in stress |
| 06/14/2001 | WO2001042469A1 Novel human transporter protein and polynucleotides encoding the same |
| 06/14/2001 | WO2001042467A2 Genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/14/2001 | WO2001042466A2 Zvwf1: a member of the von willebrand factor type a domain superfamily |
| 06/14/2001 | WO2001042465A2 Chordin-like molecules and uses thereof |
| 06/14/2001 | WO2001042464A2 Human preoptic regulatory factor-2 and uses thereof |
| 06/14/2001 | WO2001042463A1 Improving stability of flint through o-linked glycosylation |
| 06/14/2001 | WO2001042462A2 Phospholipase a2 inhibitory peptides from python reticulatus |
| 06/14/2001 | WO2001042461A2 Apoptin-associating protein |
| 06/14/2001 | WO2001042460A1 Polynucleotides, polypeptides, remedies for cancer and vaccines |
| 06/14/2001 | WO2001042459A1 Apoptosis inhibitory polypeptide, gene and polynucleotide encoding it and compositions containing the same |
| 06/14/2001 | WO2001042458A1 Method of examining vulgar psoriasis |
| 06/14/2001 | WO2001042453A1 Structural coordinate and nmr chemical shift of protein and utilization thereof |
| 06/14/2001 | WO2001042452A1 Novel promoter sequences and utilization thereof |
| 06/14/2001 | WO2001042451A2 FULL-LENGTH HUMAN cDNAs ENCODING POTENTIALLY SECRETED PROTEINS |
| 06/14/2001 | WO2001042449A2 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | WO2001042445A2 USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS |
| 06/14/2001 | WO2001042444A2 Methods for expression of genes in primates |
| 06/14/2001 | WO2001042442A2 Activation of endogenous genes by genomic introduction of a replicon |
| 06/14/2001 | WO2001042441A2 Plastid transformation |
| 06/14/2001 | WO2001042430A1 Fhar1, a ring finger protein |
| 06/14/2001 | WO2001042426A1 Penicillin production using transgenic merodiploid strains |
| 06/14/2001 | WO2001042423A2 Compositions and methods for detecting stress-inducible proteins |
| 06/14/2001 | WO2001042420A1 Production of peptides by fedbatch cultivation of a microorganism |
| 06/14/2001 | WO2001042307A1 MUTANT ERα AND TEST SYSTEMS FOR TRANSACTIVATION |
| 06/14/2001 | WO2001042306A2 Chimeric peptides (short b-cell epitope joined to a t-cell epitope) and their use for immunization |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042304A1 Interleukin-1 receptor antagonist-related molecules and uses thereof |
| 06/14/2001 | WO2001042303A1 Secreted protein zcmp2, a protein with homology to the complement component c1r |
| 06/14/2001 | WO2001042302A1 HUMAN PROTEIN AND cDNA |
| 06/14/2001 | WO2001042301A1 Interferon-alpha induced gene |
| 06/14/2001 | WO2001042300A1 Process for producing functional silk fibroin and utilization of the same |
| 06/14/2001 | WO2001042299A2 Hepatitis virus sentinel virus i (svi) |
| 06/14/2001 | WO2001042298A1 Multimeric forms of tnf superfamily ligands |
| 06/14/2001 | WO2001042297A2 Clasp-3 transmembrane protein |
| 06/14/2001 | WO2001042296A2 Clasp-5 transmembrane protein |
| 06/14/2001 | WO2001042295A2 Clasp-7 transmembrane protein |
| 06/14/2001 | WO2001042294A2 Clasp-4 transmembrane protein |
| 06/14/2001 | WO2001042292A2 Secreted polypeptide zsig87 |
| 06/14/2001 | WO2001042291A2 Polynucleotides and polypeptides encoded thereby |
| 06/14/2001 | WO2001042290A2 Novel steroid-activated nuclear receptors and uses therefor |
| 06/14/2001 | WO2001042289A2 Tetraspan polypetides and polynucleotides encoding same |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042287A2 Putative human g-protein coupled receptors |
| 06/14/2001 | WO2001042286A2 Human leucine rich repeat-containing polypeptide and uses therefor |
| 06/14/2001 | WO2001042285A2 Extracellular matrix and cell adhesion proteins as well as genes encoding them |
| 06/14/2001 | WO2001042284A2 Protein comprising ig-like domain 4 of a vegf receptor mediates receptor dimerization, but not activation |
| 06/14/2001 | WO2001042283A2 Sex-chromosome-specific proteins, species specific and sperm specific proteins and methods for their identification and isolation |
| 06/14/2001 | WO2001042281A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 06/14/2001 | WO2001042280A2 Short peptides from the b4 and b5 regions of protein kinases which selectively modulate protein activity |
| 06/14/2001 | WO2001042279A2 Complementary peptide ligands generated from plant genomes |
| 06/14/2001 | WO2001042278A2 Complementary peptide ligands generated from microbial genome sequences |
| 06/14/2001 | WO2001042277A2 Complementary peptide ligands generated from the human genome |
| 06/14/2001 | WO2001042276A1 Complementary peptide ligands generated from higher eukaryote genome sequences |